Plaza OB/GYN in Houston Offering First and Only FDA-Approved HSDD Treatment for Women
Houston, TX (PRWEB) March 23, 2016 -- Plaza OB/GYN recently became a qualified prescriber of Addyi™, the first and only FDA-approved treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Addyi™ is prescribed for the treatment of premenopausal women with acquired, generalized Hypoactive Sexual Desire Disorder (HSDD) for low sexual desire with no lack of sexual drive in the past.
"We're excited to begin administering this revolutionary treatment for women in the Houston area," Dr. Isam Balat said. "Addyi™ has the power to change the lives of many women facing low sexual desire and ultimately help restore their sexual drive."
A non-hormonal prescription pill, Addyi™ helps women regain their sexual drive who have not gone through menopause, not had problems with low sexual desire in the past, and have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner.
A qualified prescriber, Plaza OB/GYN has completed the Addyi Risk Evaluation and Mitigation Strategy (REMS) Program Prescriber Requirements. The Addyi™ REMS program enables prescribers to be trained, successfully complete a knowledge assessment, and enroll to be a certified prescriber aware of the medication's benefits and risks.
About Plaza OB/GYN Associates, P.A.
Serving Houston since 1998, Plaza OB/GYN was founded by one of Houston's top OB/GYNs Dr. Isam Balat, M.D. Plaza OB-GYN provides compassionate, state-of-the-art gynecological and obstetrical care for women, including Well Women exams, obstetrics, minimally invasive and in-office procedures, and bio-identical hormone replacement therapy. Operating at the Binz Surgery Center, Plaza OB/GYN is affiliated with five hospitals in the Houston Area and the Binz Weight Loss Center.
Julia Gonzales, Plaza OB/GYN, http://www.plazaobg.com/, +1 (713) 600-8912, [email protected]
Share this article